An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)
Clinical trial NCT02574260 · COMPLETED
Trial details
- NCT number
- NCT02574260
- Sponsor
- BioVex Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-01-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.